Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
BackgroundReimbursement policies influence access of patients to orphan drugs in the European countries.ObjectivesTo provide a comprehensive description of orphan drug reimbursement policies and to assess reimbursement decision-making process in the EU-CEE countries as well as the impact of the type...
Saved in:
Main Authors: | Krzysztof Piotr Malinowski (Author), Paweł Kawalec (Author), Wojciech Trąbka (Author), Marcin Czech (Author), Guenka Petrova (Author), Manoela Manova (Author), Alexandra Savova (Author), Pero Draganić (Author), Lenka Vostalová (Author), Juraj Slabý (Author), Agnes Männik (Author), Kristóf Márky (Author), Zinta Rugaja (Author), Jolanta Gulbinovic (Author), Tomas Tesar (Author), Marian Sorin Paveliu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
by: Maria Kamusheva, et al.
Published: (2018) -
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
by: Maria Kamusheva, et al.
Published: (2018) -
Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review
by: Paweł Kawalec, et al.
Published: (2017) -
Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
by: Szczepan Jakubowski, et al.
Published: (2024) -
Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
by: Paweł Kawalec, et al.
Published: (2017)